We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Pfizer and Bristol-Myers Squibb Finalize Agreement for Worldwide Collaboration on Metabolic Disorders Program

News   Aug 30, 2007

 
Pfizer and Bristol-Myers Squibb Finalize Agreement for Worldwide Collaboration on Metabolic Disorders Program
 
 
Advertisement
 

RELATED ARTICLES

Next-generation Sequencing To Provide Precision Medicine for Rare Metabolic Disorders

News

Scientists have uncovered the genetic basis of aromatase deficiency – a rare metabolic disorder – using next-generation sequencing, paving the way towards precision medicine.

READ MORE

Novel Vaccine Removes Aged Immune Cells in Mice

News

In a new study, researchers from Osaka University developed a novel vaccine that removes aged immune cells and then demonstrated an improvement of diabetes-associated metabolic derangements by vaccinating obese mice.

READ MORE

Novel Strategy Generates Useful Compounds for Drug Synthesis

News

A team of scientists has designed a novel catalytic method that can generate useful chiral compounds. This new strategy could provide an effective synthetic way to design pharmaceutical products.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE